AU2001248303A1 - Lipid-based systems for targeting diagnostic agents - Google Patents
Lipid-based systems for targeting diagnostic agentsInfo
- Publication number
- AU2001248303A1 AU2001248303A1 AU2001248303A AU4830301A AU2001248303A1 AU 2001248303 A1 AU2001248303 A1 AU 2001248303A1 AU 2001248303 A AU2001248303 A AU 2001248303A AU 4830301 A AU4830301 A AU 4830301A AU 2001248303 A1 AU2001248303 A1 AU 2001248303A1
- Authority
- AU
- Australia
- Prior art keywords
- lipid
- diagnostic agents
- based systems
- targeting
- targeting diagnostic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940039227 diagnostic agent Drugs 0.000 title abstract 2
- 239000000032 diagnostic agent Substances 0.000 title abstract 2
- 150000002632 lipids Chemical class 0.000 title abstract 2
- 230000008685 targeting Effects 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Cosmetics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000616 | 2000-04-12 | ||
DKPA200000616 | 2000-04-12 | ||
PCT/DK2001/000269 WO2001076644A2 (fr) | 2000-04-12 | 2001-04-11 | Systeme a base de lipides permettant de cibler des agents de diagnostic |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001248303A1 true AU2001248303A1 (en) | 2001-10-23 |
Family
ID=8159422
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001248302A Abandoned AU2001248302A1 (en) | 2000-04-12 | 2001-04-11 | Lipid-based drug delivery systems against parasitic infections |
AU2001248303A Abandoned AU2001248303A1 (en) | 2000-04-12 | 2001-04-11 | Lipid-based systems for targeting diagnostic agents |
AU2001248301A Abandoned AU2001248301A1 (en) | 2000-04-12 | 2001-04-11 | Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001248302A Abandoned AU2001248302A1 (en) | 2000-04-12 | 2001-04-11 | Lipid-based drug delivery systems against parasitic infections |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001248301A Abandoned AU2001248301A1 (en) | 2000-04-12 | 2001-04-11 | Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin |
Country Status (11)
Country | Link |
---|---|
US (4) | US7368254B2 (fr) |
EP (3) | EP1272225B1 (fr) |
JP (3) | JP2003530362A (fr) |
AT (2) | ATE382333T1 (fr) |
AU (3) | AU2001248302A1 (fr) |
CY (2) | CY1105792T1 (fr) |
DE (3) | DE60122304T2 (fr) |
DK (3) | DK1272161T3 (fr) |
ES (3) | ES2295149T3 (fr) |
PT (3) | PT1272225E (fr) |
WO (3) | WO2001076644A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020001614A1 (en) * | 2000-02-10 | 2002-01-03 | Kent Jorgensen | Lipid-based drug delivery systems containing phospholipase A2 degradable lipid derivatives and the therapeutic uses thereof |
EP1391207A1 (fr) * | 2001-04-24 | 2004-02-25 | Luis Alberto Costa | Utilisation d'une phospholipase a2 pour la preparation de compositions pharmaceutiques et/ou cosmetiques pour la prevention et/ou le traitement local et/ou systemique de maladies et/ou de processus provoques par des patogenes intra ou extra cellulaires exprimant des phospholipides de membrane |
US20050123925A1 (en) * | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
AU2004264857B2 (en) * | 2003-07-09 | 2010-06-10 | Sutter West Bay Hospitals | Remote detection of substance delivery to cells |
US20050266066A1 (en) * | 2003-10-20 | 2005-12-01 | Nof Corporation | Phospholipid membrane preparation |
WO2005077963A1 (fr) * | 2004-01-16 | 2005-08-25 | Institut Superieur Agricole De Beauvais | DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes. |
EP1710574A4 (fr) * | 2004-01-28 | 2008-09-17 | Ltt Bio Pharma Co Ltd | Procede de balayage de compose inoffensif pour la muqueuse gastrique |
DE102004010387A1 (de) * | 2004-03-03 | 2005-09-22 | Siemens Ag | Kontrastmittel für die Röntgen-Computertomographie |
WO2006086992A2 (fr) * | 2005-02-18 | 2006-08-24 | Liplasome Pharma A/S | Systemes d'apport de medicament contenant des derives de promedicament lipidique degradant la phospholipase a2 et utilisations therapeutiques de ces derniers par exemple en tant qu'agents de guerison des blessures ou en tant que ligands de recepteurs actives par un proliferateur au peroxysome |
JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
WO2006099445A2 (fr) * | 2005-03-14 | 2006-09-21 | Massachusetts Institute Of Technology | Nanocellules pour le diagnostic et le traitement de maladies et troubles |
ES2385513T3 (es) * | 2005-10-11 | 2012-07-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Composición para administración nasal |
EP1981488A1 (fr) * | 2005-12-23 | 2008-10-22 | Jado Technologies GmbH | Moyens et méthodes pour le traitement prophylactique et thérapeutique de maladies allergiques |
JP2011026294A (ja) * | 2009-06-26 | 2011-02-10 | Canon Inc | 化合物 |
US8993715B2 (en) * | 2009-07-06 | 2015-03-31 | Canon Kabushiki Kaisha | Labeled protein and method for obtaining the same |
NZ598906A (en) | 2009-08-21 | 2014-08-29 | Targeted Delivery Technologies Ltd | Vesicular formulations |
DK177532B1 (en) | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
DK177529B1 (en) * | 2009-10-23 | 2013-09-08 | Bio Bedst Aps | Liposomes with improved storage stability |
WO2011102906A1 (fr) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Système de distribution de nanoémulsions de lipide-huile-eau pouvant recevoir une image |
WO2011102905A1 (fr) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Système d'administration diagnostique de nano-émulsion lipide-huile-eau imageable |
WO2011102904A1 (fr) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Système d'administration thérapeutique de nano-émulsion lipide-huile-eau imageable |
WO2013131164A1 (fr) * | 2012-03-09 | 2013-09-12 | Universidade Federal De Minas Gerais - Ufmg | Composition pharmaceutique contenant des liposomes classiques et liposomes à circulation prolongée pour le traitement de la leishmaniose viscérale |
GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
WO2014047116A1 (fr) * | 2012-09-18 | 2014-03-27 | Comfort Care For Animals Llc | Liposomes d'encapsulation |
EP3954361A1 (fr) | 2015-06-30 | 2022-02-16 | Sequessome Technology Holdings Limited | Compositions multiphasiques |
EP3538546A1 (fr) | 2016-11-14 | 2019-09-18 | Novartis AG | Compositions, méthodes et utilisations thérapeutiques associées à une protéine fusogène minion |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0714865B2 (ja) * | 1986-10-28 | 1995-02-22 | 武田薬品工業株式会社 | リポソ−ム製剤およびその製造法 |
US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5925375A (en) * | 1987-05-22 | 1999-07-20 | The Liposome Company, Inc. | Therapeutic use of multilamellar liposomal prostaglandin formulations |
FR2638639A1 (fr) * | 1988-11-08 | 1990-05-11 | Parincos Parfumerie Cosmet Int | Composition et procede d'obtention de liposomes oligolamellaires en vue d'une application en cosmetologie et dermatologie topique |
US5153000A (en) * | 1988-11-22 | 1992-10-06 | Kao Corporation | Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome |
US4874794A (en) * | 1989-04-28 | 1989-10-17 | Lidak Biopharmaceuticals | Inflammatory disease treatment |
JPH0370491A (ja) | 1989-08-04 | 1991-03-26 | Toshiba Corp | 電動機制御装置 |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5705187A (en) * | 1989-12-22 | 1998-01-06 | Imarx Pharmaceutical Corp. | Compositions of lipids and stabilizing materials |
JP3765579B2 (ja) * | 1990-08-24 | 2006-04-12 | イーデーエーアー アーゲー | 作用物質投与用超微小滴状調剤 |
US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
US5723115A (en) * | 1991-05-02 | 1998-03-03 | W. Alton Jones Cell Science Center, Inc. | Inhibition of adipose tissue development and obesity |
US5484911A (en) * | 1993-04-01 | 1996-01-16 | Health Research, Inc. | Nucleoside 5'-diphosphate conjugates of ether lipids |
DE4408011C1 (de) * | 1994-03-10 | 1995-11-02 | Max Delbrueck Centrum | Pharmazeutisches Mittel zur Tumortherapie |
US20020048596A1 (en) * | 1994-12-30 | 2002-04-25 | Gregor Cevc | Preparation for the transport of an active substance across barriers |
US5942246A (en) * | 1996-02-16 | 1999-08-24 | The Liposome Company, Inc. | Etherlipid containing multiple lipid liposomes |
US5827836A (en) * | 1996-11-15 | 1998-10-27 | Clarion Pharmaceuticals Inc. | Retinoid glycerol phospholipid conjugates |
US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
US6444640B1 (en) * | 1999-09-30 | 2002-09-03 | Ludwig Institute For Cancer Research | Compositions of trail and DNA damaging drugs and uses thereof |
-
2001
- 2001-04-11 ES ES01921262T patent/ES2295149T3/es not_active Expired - Lifetime
- 2001-04-11 AU AU2001248302A patent/AU2001248302A1/en not_active Abandoned
- 2001-04-11 EP EP01921263A patent/EP1272225B1/fr not_active Expired - Lifetime
- 2001-04-11 PT PT01921263T patent/PT1272225E/pt unknown
- 2001-04-11 JP JP2001574159A patent/JP2003530362A/ja not_active Withdrawn
- 2001-04-11 JP JP2001574073A patent/JP2003530338A/ja not_active Withdrawn
- 2001-04-11 WO PCT/DK2001/000269 patent/WO2001076644A2/fr active IP Right Grant
- 2001-04-11 WO PCT/DK2001/000267 patent/WO2001076555A2/fr active IP Right Grant
- 2001-04-11 DK DK01921262T patent/DK1272161T3/da active
- 2001-04-11 US US10/239,515 patent/US7368254B2/en not_active Expired - Fee Related
- 2001-04-11 DE DE60122304T patent/DE60122304T2/de not_active Expired - Fee Related
- 2001-04-11 WO PCT/DK2001/000268 patent/WO2001076556A2/fr active IP Right Grant
- 2001-04-11 AU AU2001248303A patent/AU2001248303A1/en not_active Abandoned
- 2001-04-11 US US10/239,527 patent/US7166297B2/en not_active Expired - Fee Related
- 2001-04-11 US US10/239,514 patent/US20030170297A1/en not_active Abandoned
- 2001-04-11 JP JP2001574074A patent/JP2003530339A/ja not_active Withdrawn
- 2001-04-11 DK DK01921263T patent/DK1272225T3/da active
- 2001-04-11 ES ES01921263T patent/ES2270991T3/es not_active Expired - Lifetime
- 2001-04-11 DE DE60132184T patent/DE60132184T2/de not_active Expired - Fee Related
- 2001-04-11 PT PT01921262T patent/PT1272161E/pt unknown
- 2001-04-11 EP EP01921262A patent/EP1272161B1/fr not_active Expired - Lifetime
- 2001-04-11 AU AU2001248301A patent/AU2001248301A1/en not_active Abandoned
- 2001-04-11 AT AT01921262T patent/ATE382333T1/de not_active IP Right Cessation
- 2001-04-11 ES ES01921261T patent/ES2280355T3/es not_active Expired - Lifetime
- 2001-04-11 EP EP01921261A patent/EP1272160B1/fr not_active Expired - Lifetime
- 2001-04-11 AT AT01921263T patent/ATE336267T1/de not_active IP Right Cessation
- 2001-04-11 DE DE60126072T patent/DE60126072T2/de not_active Expired - Fee Related
- 2001-04-11 DK DK01921261T patent/DK1272160T3/da active
- 2001-04-11 PT PT01921261T patent/PT1272160E/pt unknown
-
2006
- 2006-11-16 CY CY20061101675T patent/CY1105792T1/el unknown
- 2006-12-12 US US11/609,773 patent/US20070134153A1/en not_active Abandoned
-
2007
- 2007-04-16 CY CY20071100522T patent/CY1106462T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001248303A1 (en) | Lipid-based systems for targeting diagnostic agents | |
BG103438A (en) | Improvements of or in relation to diagnostic/therapeutical forms | |
GB0222495D0 (en) | Compounds | |
EP1470146B8 (fr) | Anticorps contre l'antigene muc18 | |
GB9716656D0 (en) | Chemical compounds | |
UA83194C2 (ru) | Производные пиримидина и их применение как модуляторов св2 | |
HK1088845A1 (en) | Use of parthenolide derivatives as antileukemic and cytotoxic agents | |
ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
AU3227700A (en) | Skin sanitizing compositions | |
AU2119200A (en) | Medicament | |
EP2434022A3 (fr) | Utilisation d'antigènes A33 et de blocage | |
ECSP055965A (es) | Oxatiincarboxamidas | |
GT200000035AA (es) | Derivados de resorcinol, (solicitud fraccionaria no. 1 derivada de la patente pi-2000-0035) | |
MXPA02003398A (es) | Composiciones aromatizantes antimicrobianas. | |
AU4179399A (en) | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders | |
DE69521122D1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
BR0009194A (pt) | Composição do resorcinol | |
BR0010699A (pt) | Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários | |
DE60041198D1 (de) | Antimikrobielle zusammensetzungen | |
DE69831737D1 (de) | Neurotrypsin | |
NO973666L (no) | Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom | |
MY130532A (en) | Combination of biological and chemical agents to combat rodents | |
AU2001238470A1 (en) | 9-alkylamino-1-nitroacridine derivatives | |
UY25164A1 (es) | 3-ariluracilos herbicidas |